Management and treatment of chronic urticaria (CU)

Developments increasing our understanding of chronic urticaria have resulted in the simplification and improvement of available treatments. Currently, many treatments target mast cell mediators, but we can now disrupt mast cell activation with the anti‐IgE antibody omalizumab, which has markedly adv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2015-06, Vol.29 (S3), p.16-32
Hauptverfasser:	Maurer, M., Church, M.K., Gonçalo, M., Sussman, G., Sánchez-Borges, M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angiotensin-Converting Enzyme Inhibitors - adverse effects Anti-Inflammatory Agents, Non-Steroidal - adverse effects Child Chronic Disease Cold Temperature - adverse effects Female Histamine H1 Antagonists - therapeutic use Humans Omalizumab - therapeutic use Pregnancy Pressure - adverse effects Sunlight - adverse effects Urticaria - chemically induced Urticaria - drug therapy Urticaria - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!